Myocardial ischemia is a medical condition characterized by reduced blood flow to the heart muscle, usually due to the obstruction or narrowing of coronary arteries. This restriction in blood supply deprives the heart muscle of oxygen and vital nutrients, leading to potential damage or cell death. The most common cause of myocardial ischemia is atherosclerosis, where the arteries become narrowed by the buildup of fatty deposits, cholesterol, and other substances. The condition can manifest with symptoms such as chest pain or discomfort, known as angina, and in severe cases, it can result in a heart attack. Timely diagnosis and intervention are crucial to managing myocardial ischemia and preventing further complications, emphasizing the importance of lifestyle modifications, medication, and, in some cases, surgical interventions to restore blood flow and preserve heart function.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation